Author： Molander Pauliina af Björkesten Clas-Göran Mustonen Harri Haapamäki Johanna Vauhkonen Matti Kolho Kaija-Leena Färkkilä Martti Sipponen Taina
Publisher： Blackwell Publishing
ISSN： 1078-0998
Source： Inflammatory Bowel Diseases, Vol.18, Iss.11, 2012-11, pp. : 2011-2017
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Biologic Therapy for Inflammatory Bowel Disease
By Ardizzone Sandro Gabriele Bianchi Porro
Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. :
Current Therapy of Inflammatory Bowel Disease in Children
By Rufo Paul A. Bousvaros Athos
Pediatric Drugs, Vol. 8, Iss. 5, 2006-01 ,pp. :
Infliximab Therapy in Children and Adolescents with Inflammatory Bowel Disease
By Veres Gabor
Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. :
Pharmacogenetics of Therapy in Inflammatory Bowel Disease Patients
Current Pharmacogenomics, Vol. 5, Iss. 3, 2007-09 ,pp. :